Effect of sarpogrelate hydrochloride, a 5-hydroxytryptamine2 receptor antagonist, on allograft arteriosclerosis after aortic transplantation in rats

Susumu Watada, Hirohisa Harada, Kentaro Matsubara, Hideaki Obara, Kenji Matsumoto, Nobutoshi Ando, Yuukou Kitagawa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Sarpogrelate hydrochloride, a 5-hydroxytryptamine2 receptor antagonist, is known to prevent serotonin-induced neointimal hyperplasia. We examined the effect of this agent on allograft arteriosclerosis in a rat model of aortic transplantation. Methods: Rats were given an aortic isograft or allograft and oral administration of either saline vehicle alone or 20. mg/kg daily of sarpogrelate for 8. weeks. The grafts were then harvested, and the lumen diameter and the thickness of the intima and media were measured. Comparisons were made between measurement results in isografts and allografts from rats treated and not treated with sarpogrelate. Immunohistochemistry assessments were used to detect expression of serotonin in graft specimens. Results: For both allografts and isografts, significantly less intimal thickening was observed in specimens from rats given sarpogrelate compared with rats given saline. Sarpogrelate had no effect on medial thickening in either graft type. Serotonin was detected in allografts from rats given saline alone but not in allografts from rats given sarpogrelate or in isografts. Conclusions: Sarpogrelate hydrochloride may mitigate arteriosclerosis in allografts. Platelet aggregation and serotonin may be correlated with intimal thickening associated with chronic rejection.

Original languageEnglish
Pages (from-to)162-166
Number of pages5
JournalTransplant Immunology
Volume29
Issue number1-4
DOIs
Publication statusPublished - 2013

Fingerprint

Arteriosclerosis
Allografts
Isografts
Transplantation
Serotonin
Tunica Intima
Transplants
sarpogrelate
Platelet Aggregation
Hyperplasia
Oral Administration
Immunohistochemistry

Keywords

  • Allograft arteriosclerosis
  • Rat
  • Sarpogrelate hydrochloride
  • Transplantation

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Transplantation

Cite this

Effect of sarpogrelate hydrochloride, a 5-hydroxytryptamine2 receptor antagonist, on allograft arteriosclerosis after aortic transplantation in rats. / Watada, Susumu; Harada, Hirohisa; Matsubara, Kentaro; Obara, Hideaki; Matsumoto, Kenji; Ando, Nobutoshi; Kitagawa, Yuukou.

In: Transplant Immunology, Vol. 29, No. 1-4, 2013, p. 162-166.

Research output: Contribution to journalArticle

@article{35e8e804abf94e0d9b1dd3177ef8640f,
title = "Effect of sarpogrelate hydrochloride, a 5-hydroxytryptamine2 receptor antagonist, on allograft arteriosclerosis after aortic transplantation in rats",
abstract = "Background: Sarpogrelate hydrochloride, a 5-hydroxytryptamine2 receptor antagonist, is known to prevent serotonin-induced neointimal hyperplasia. We examined the effect of this agent on allograft arteriosclerosis in a rat model of aortic transplantation. Methods: Rats were given an aortic isograft or allograft and oral administration of either saline vehicle alone or 20. mg/kg daily of sarpogrelate for 8. weeks. The grafts were then harvested, and the lumen diameter and the thickness of the intima and media were measured. Comparisons were made between measurement results in isografts and allografts from rats treated and not treated with sarpogrelate. Immunohistochemistry assessments were used to detect expression of serotonin in graft specimens. Results: For both allografts and isografts, significantly less intimal thickening was observed in specimens from rats given sarpogrelate compared with rats given saline. Sarpogrelate had no effect on medial thickening in either graft type. Serotonin was detected in allografts from rats given saline alone but not in allografts from rats given sarpogrelate or in isografts. Conclusions: Sarpogrelate hydrochloride may mitigate arteriosclerosis in allografts. Platelet aggregation and serotonin may be correlated with intimal thickening associated with chronic rejection.",
keywords = "Allograft arteriosclerosis, Rat, Sarpogrelate hydrochloride, Transplantation",
author = "Susumu Watada and Hirohisa Harada and Kentaro Matsubara and Hideaki Obara and Kenji Matsumoto and Nobutoshi Ando and Yuukou Kitagawa",
year = "2013",
doi = "10.1016/j.trim.2013.07.001",
language = "English",
volume = "29",
pages = "162--166",
journal = "Transplant Immunology",
issn = "0966-3274",
publisher = "Elsevier",
number = "1-4",

}

TY - JOUR

T1 - Effect of sarpogrelate hydrochloride, a 5-hydroxytryptamine2 receptor antagonist, on allograft arteriosclerosis after aortic transplantation in rats

AU - Watada, Susumu

AU - Harada, Hirohisa

AU - Matsubara, Kentaro

AU - Obara, Hideaki

AU - Matsumoto, Kenji

AU - Ando, Nobutoshi

AU - Kitagawa, Yuukou

PY - 2013

Y1 - 2013

N2 - Background: Sarpogrelate hydrochloride, a 5-hydroxytryptamine2 receptor antagonist, is known to prevent serotonin-induced neointimal hyperplasia. We examined the effect of this agent on allograft arteriosclerosis in a rat model of aortic transplantation. Methods: Rats were given an aortic isograft or allograft and oral administration of either saline vehicle alone or 20. mg/kg daily of sarpogrelate for 8. weeks. The grafts were then harvested, and the lumen diameter and the thickness of the intima and media were measured. Comparisons were made between measurement results in isografts and allografts from rats treated and not treated with sarpogrelate. Immunohistochemistry assessments were used to detect expression of serotonin in graft specimens. Results: For both allografts and isografts, significantly less intimal thickening was observed in specimens from rats given sarpogrelate compared with rats given saline. Sarpogrelate had no effect on medial thickening in either graft type. Serotonin was detected in allografts from rats given saline alone but not in allografts from rats given sarpogrelate or in isografts. Conclusions: Sarpogrelate hydrochloride may mitigate arteriosclerosis in allografts. Platelet aggregation and serotonin may be correlated with intimal thickening associated with chronic rejection.

AB - Background: Sarpogrelate hydrochloride, a 5-hydroxytryptamine2 receptor antagonist, is known to prevent serotonin-induced neointimal hyperplasia. We examined the effect of this agent on allograft arteriosclerosis in a rat model of aortic transplantation. Methods: Rats were given an aortic isograft or allograft and oral administration of either saline vehicle alone or 20. mg/kg daily of sarpogrelate for 8. weeks. The grafts were then harvested, and the lumen diameter and the thickness of the intima and media were measured. Comparisons were made between measurement results in isografts and allografts from rats treated and not treated with sarpogrelate. Immunohistochemistry assessments were used to detect expression of serotonin in graft specimens. Results: For both allografts and isografts, significantly less intimal thickening was observed in specimens from rats given sarpogrelate compared with rats given saline. Sarpogrelate had no effect on medial thickening in either graft type. Serotonin was detected in allografts from rats given saline alone but not in allografts from rats given sarpogrelate or in isografts. Conclusions: Sarpogrelate hydrochloride may mitigate arteriosclerosis in allografts. Platelet aggregation and serotonin may be correlated with intimal thickening associated with chronic rejection.

KW - Allograft arteriosclerosis

KW - Rat

KW - Sarpogrelate hydrochloride

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=84897048086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897048086&partnerID=8YFLogxK

U2 - 10.1016/j.trim.2013.07.001

DO - 10.1016/j.trim.2013.07.001

M3 - Article

C2 - 23851153

AN - SCOPUS:84897048086

VL - 29

SP - 162

EP - 166

JO - Transplant Immunology

JF - Transplant Immunology

SN - 0966-3274

IS - 1-4

ER -